CAMBRIDGE, Mass., March 3, 2009 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that management will present a company overview at two upcoming conferences.
* Adelene Q. Perkins, president and chief business officer, will present at the Barclays Capital Global Healthcare Conference in Miami on March 10, 2009 at 10:45 a.m. EST. * Steven H. Holtzman, chair and chief executive officer, will present at the Cowen and Company 29th Annual Healthcare Conference in Boston on March 16, 2009 at 4:40 p.m. EST.
A live webcast of Infinity's presentations will be accessible on the company's website at http://www.infi.com.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for the treatment of cancer and related conditions. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging cancer pathways. Infinity's two most advanced programs in Hsp90 inhibition and Hedgehog signaling pathway inhibition are evidence of its innovative approach to oncology drug discovery and development. For more information on Infinity, please refer to the company's website at http://www.infi.com.